Activity Preview

Live

SA: FOCUS PTSD MOC Workbook Self-Assessment

Activity Type:

  • Self-Assessment


Release Date: 8/1/2014

Expiration Date: 8/31/2020

  • AAPA Self-Assessment: 12
  • AMA PRA Category 1 Physician: 12
  • Participation: 12

Register

Overview

The FOCUS Posttraumatic Stress Disorder Maintenance of Certification (MOC) Workbook is a collection of practical and evidence-based materials to help psychiatrists develop and maintain a sound, up-to-date foundation of medical knowledge and clinical expertise, ultimately improving patient care. Designed to be a “one stop” resource to meet MOC requirements, the book aims to help psychiatrists evaluate their knowledge and clinical practice, initiate a program of quality improvement, and advance their assessment, communication, diagnostic, and treatment skills.

To achieve these goals, the workbook includes:

  • A Self-Assessment test consisting of 50 multiple-choice questions on posttraumatic stress disorder (PTSD), designed to test current knowledge and its clinical application, thus helping the clinician identify areas of competence and those requiring additional study and improvement.
  • A Performance in Practice Clinical Module, a guided practice improvement program designed to meet Part 4 American Board of Psychiatry and Neurology (ABPN) MOC requirements for clinical modules. This module is divided into three stages: Chart Review, Improvement Plan, and a second or retrospective Chart Review.
  • Resources for use in an improvement plan, including a Real-Time Assessment Tool for Patients With PTSD, the executive summary of the APA Practice Guideline for the Treatment of Patients With PTSD, and a selection of influential publications on posttraumatic stress disorder to help psychiatrists stay current with advances in research and treatment.
  • Peer and Patient Survey Forms for use in the Feedback Modules (Part 4 of MOC)
  • A detailed description and explanation of the MOC Program as presented by the ABPN, including details on record keeping, phase-in schedule, and auditing. 

Exercises provided in the workbook are to be completed both in the book and online. Continuing medical education (CME) activities were developed in compliance with ABPN reporting requirements, and credit for these activities is recorded in this activity and its related activities. The FOCUS program aims to educate physicians, refresh their knowledge and skills, and facilitate the documentation of their ongoing professional development and competency.

 

CME Credit and MOC Approval

The Self-Assessment in Posttraumatic Stress Disorder (PTSD) is designed to test current knowledge and its clinical application. The self-assessment is a component of an individualized program of lifelong learning and is designed to identify areas in which practitioners may benefit from further study. It is approved by the American Board of Psychiatry and Neurology (ABPN) for MOC Part 2.

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring material for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The activity requires purchase of the workbook prior to accessing the course, in the workbook you are given an CME Code for credit that you will be prompted to enter in the Group ID on the purchase step.

If you do not already own the workbook, click here to purchase

Educational Objectives

By completing the activities in this workbook, physicians will: 1) assess their strengths and weaknesses in the diagnosis and treatment of patients with PTSD; 2) evaluate their knowledge and clinical skills; 3) participate in a program of quality improvement and develop and implement their own plan of improvement; and 4) advance their assessment, communication, diagnostic, and treatment skills and improve patient care for patients with PTSD.

Target Audience

Psychiatrists participating in MOC and other psychiatrists in clinical practice; psychiatric residents and fellows; physicians who wish to improve their knowledge of clinical psychiatry and patient care in PTSD.

Estimated Time to Complete

Estimated Time to Complete the Activity: Up to 12 hours
Begin Date: August 2014 
Program Review Date: August 2017
End Date: 
August 31, 2020

How to Earn Credit

This self-assessment activity enables the physician to learn about strengths and weaknesses in a topic area and identify areas for further study. To earn AMA PRA Category 1 Credit™ as well as document your completion of an ABPN approved MOC program for Self-Assessment; input your answers to the 50 multiple choice questions online. The minimum passing score for this activity is fulfilled by your receipt of a score report and completion of all questions. In the online program, you will input your self-assessment answers, read the rationale and reference for the question, link out to references, claim credit, evaluate the program, and obtain your confidential self-assessment score report and peer comparison. Your score report and peer comparison appear as the final section of the course called “Peer Comparison Report”. This a dynamic report that will change as the peer group increases, so it is recommended that you periodically access this link by re-launching the course from your transcript to see where your results stack up as compared to your peers.

Continuing Education Credit and ABPN Approval Statement

The APA is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring material for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The FOCUS Posttraumatic Stress Disorder Maintenance of Certification (MOC) Workbook Self-Assessment is approved by ABPN for MOC Part 2. 

APA reports MOC completion data on behalf of our members directly to ABPN, however, diplomates are still required to log on to their ABPN Physician Folios at least once per calendar year to attest to completion of their MOC activities.

Faculty and Planner Disclosures

No support from commercial sources was used in the development and production of this CME program. Deborah J. Hales, M.D., Director, American Psychiatric Association Division of Education, Arlington, Virginia No financial affiliations with commercial organizations. Mark Hyman Rapaport, M.D., Chairman, Department of Psychiatry, Emory University School of Medicine, Atlanta, Georgia Consultant: Pax, Inc. Grant/Research Support: NIMH, NCCAM. Tanya R. Anderson, M.D., Assistant Professor of Psychiatry, Director, Comprehensive Assessment and ResponseTraining System, University of Illinois at Chicago Speakers Bureau: AstraZeneca Carl C. Bell, M.D., President/CEO, Community Mental Health Council and Foundation, Inc., and Professor of Psychiatry and Public Health, University of Illinois at Chicago. No financial affiliations with commercial organizations. David M. Benedek, M.D. - Associate Professor of Psychiatry and Scientist, Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences, Bethesda, Maryland. No financial affiliations with commercial organizations. Robert J. Boland, M.D., Professor of Psychiatry and Human Behavior, Alpert School of Medicine, Brown University, Providence, Rhode Island No financial affiliations with commercial organizations. J. Michael Bostwick, M.D., Assistant Professor of Psychiatry, Mayo Medical School Consultant, Department of Psychiatry and Psychology, Mayo Clinic and Foundation, Rochester, Minnesota No financial affiliations with commercial organizations. John H. Coverdale, M.D., Associate Professor of Psychiatry and Medical Ethics, Baylor College of Medicine, Houston, Texas No financial affiliations with commercial organizations. Arden D. Dingle, M.D., Associate Professor, Department of Psychiatry and Behavioral Sciences, Training Director, Child and Adolescent Psychiatry, Emory University School of Medicine, Atlanta, Georgia No financial affiliations with commercial organizations. Laura B. Dunn, M.D., Assistant Professor, Department of Psychiatry, University of California, San Diego No financial affiliations with commercial organizations. Spencer Eth, M.D., Professor and Vice-Chairman, Department of Psychiatry and Behavioral Sciences, New York Medical College, and Medical Director and Senior Vice-President, Behavioral Health Services, Saint Vincent Catholic Medical Centers, New York, New York. No financial affiliations with commercial organizations. Laura Fochtmann, M.D., Professor, Department of Psychiatry and Behavioral Sciences, Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York and Practice Guidelines Medical Editor, American Psychiatric Association. No financial affiliations with commercial organizations. Suzanne Garfinkle, M.D., M.Sc., Assistant Professor of Psychiatry and Medical Education, Director, Mount Sinai Academy for Medicine and the Humanities, New York, New York No financial affiliations with commercial organizations. Waguih William IsHak, M.D., Director, Psychiatric Residency Training Program, Interim Medical Director, Outpatient Psychiatry Service, Cedars-Sinai Medical Center, Los Angeles, Assistant Clinical Professor of Psychiatry, UCLA Grant/Research Support for Clinical Trials: AstraZeneca, Janssen. Speakers Bureau: Pfizer, Inc. James W. Jefferson, M.D., Clinical Professor of Psychiatry, University of Wisconsin School of Medicine and Public Health, Distinguished Senior Scientist, Madison Institute of Medicine, Inc., Director, Healthcare Technology Systems, Inc., Madison, Wisconsin Lecture Honoraria: Arbor Scientica, GlaxoSmithKline, Lilly, Merck, Purdue, Sunovion. Stock Shareholder: Bristol-Myers Squibb, GlaxoSmithKline, SciClone. Principal: Healthcare Technology Systems, Inc. Jerald Kay, M.D., Professor and Chair, Department of Psychiatry, Wright State University School of Medicine, Dayton, Ohio No financial affiliations with commercial organizations. Scott Y.H. Kim, M.D., Assistant Professor, Department of Psychiatry, Bioethics Program, and Center for Behavioral and Decision Sciences in Medicine, University of Michigan Medical School, Ann Arbor, Michigan No financial affiliations with commercial organizations. Joan A. Lang, M.D., Professor and Chair, Department of Psychiatry, Saint Louis University, St. Louis MO No financial affiliations with commercial organizations. Martin H. Leamon, M.D., Associate Professor of Clinical Psychiatry, University of California-Davis, Sacramento No financial affiliations with commercial organizations. Alan K. Louie, M.D., Director, San Mateo County Mental Health Services, Psychiatry Residency Training Program, San Mateo, California Consultant or Speaker: Abbott Laboratories, Bristol-Myers Squibb, Cephalon, Ciba-Geigy, Eli Lilly, Forest, Glaxo Wellcome, Janssen, Parke Davis, Sandoz, SmithKline Beecham, Wyeth Ayerst. Vishal Madaan, M.D., Director, Child and Family Psychiatry Clinic, Associate Training Director, General Psychiatry Program, University of Virginia Health System, Charlottesville, Virginia Consultant: NOW Coalition for Bipolar Disorder. Research Support: Otsuka, Shire, Pfizer, Lilly, Forest, Merck. Annette M. Matthews, M.D., Psychiatrist, Portland Veterans Affairs Medical Center, Portland, Oregon, Associate Professor, Department of Psychiatry and Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon No financial affiliations with commercial organizations. John S. McIntyre, M.D., Vice President for Behavioral Health and Chair, Department of Psychiatry and Behavioral Health, Unity Health System, Rochester, New York, and Chair, APA Steering Committee on Practice Guidelines. No financial affiliations with commercial organizations. Philip R. Muskin, M.D., Professor of Clinical Psychiatry, Columbia University; Chief: Consultation-Liaison Psychiatry at Columbia University Medical Center/New York Presbyterian Hospital. No financial affiliations with commercial organizations. Patricia I. Ordorica, M.D., Associate Chief of Staff for Mental Health and Behavioral Sciences, James A. Haley VA Hospital; Clinical Director, Counterdrug Technology Assessment Center (CTAC) Drug Addiction Study; Director, Addictive Disorders, and Associate Professor of Psychiatry, University of South Florida, Tampa. Consultant/Speaker: Bristol-Meyers Squibb, Pfizer, Inc. Deepak Prabhakar, M.D., M.P.H., Attending Psychiatrist in Behavioral Health Services, Henry Ford Health Systems, Detroit, Michigan. No financial affiliations with commercial organizations. David W. Preven, M.D., Clinical Professor in the Department of Behavioral Sciences and Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York Speaker: Pfizer, Forest Rima Styra, M.D., Toronto General Hospital, University Health Network, Department of Psychiatry, Toronto, Ontario, Canada No financial affiliations with commercial organizations. Christiane Tellefsen, M.D., Clinical Assistant Professor, University of Maryland School of Medicine and JohnsHopkins University School of Medicine, Baltimore No financial affiliations with commercial organizations. Lowell D. Tong, M.D., Associate Chair of Education, Department of Psychiatry, University of California San Francisco School of Medicine No financial affiliations with commercial organizations. Marcia Verduin, M.D., Associate Professor of Psychiatry, College of Medicine, University of Central Florida, Orlando, Florida No financial affiliations with commercial organizations. Eric R. Williams, M.D., Assistant Professor of Child and Adolescent Psychiatry, University of South Carolina School of Medicine, Columbia, South Carolina No financial affiliations with commercial organizations. Isaac Wood, M.D., Professor of Psychiatry and Pediatrics, Virginia Commonwealth University, Richmond, Virginia No financial affiliations with commercial organizations. Joel Yager, M.D., Professor, Department of Psychiatry, School of Medicine, University of Colorado; Emeritus Professor, Department of Psychiatry at the University of New Mexico School of Medicine and Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA No financial affiliations with commercial organizations. Ann Thomas, CME Program Coordinator, American Psychiatric Association, Arlington, Virginia No financial affiliations with commercial organizations.

Hardware/Software Requirements

For PC users, we recommend using a computer that is running the most recent version of Microsoft Windows.
For Macintosh users, we recommend using a computer that is running OS X or later.
Although the presentations and website can be viewed on any browser, we suggest Google Chrome for PC users and the latest version of Firefox for Macintosh users. Make sure your computer's software and browsers are updated regularly for an optimal experience.

Due to the media-rich content, we recommend viewing programs at a minimum screen resolution of 800 x 600 pixels, but preferably 1024 x 768 pixels.

Register